We would love to hear your thoughts about our site and services, please take our survey here.
I don't see this dropping to placing price, ~10p looks quite stable
Yes CJ this really is a long term hold. CDX licensing is just a starter. There future is very bright here.
JHFHs £16k buy showed up delayed, always delaying the large buys
Anything in particular you wanted to highlight from that video CJ? I think I've watched every Vlad video on the Internet, have a look on the hemo website and you'll find some videos that aren't on YouTube
Nice JHFH! Built up a massive holding! :)
Vlad isn't selling or buying, Vlad will collect his shares through remuneration. Either some of the buyers in the hype are still getting out or someone with plenty of shares is exiting. What ever is causing the drop will not change the fair valuation of hemo on news day.
I didn't suggest he is selling and I'm extremely confident he is not selling. Just imagining my sadness if he did
Dead
Imagine the salty taste reading that RNS Vlad had offloaded 50m shares :'(
We are just 3 weeks away from half year results now, so very close to a guaranteed news day. That should be 30th September at 7am.
This news day could potentially be the first time we turn a profit and that would be a massive milestone for a pre clinical pharma. SP affected by P/E ratios and other stuff too.
People complaining where's the news like hemo isn't pulling off huge collaborations regularly, reaching milestones regularly. From 1 millennial to all you complainers, have some patience!
Have some patience Lilly have been collaborating on CDX for over 2 years with hemo in pre clinicals. To get all the way to the end of pre clinicals and allow a name drop, there's almost no way Lilly walk away at this point.
It must be difficult to draw up an agreement for CDX because it can be used on AML ALL and as toxicity lowering enabler, whereas the pre clinicals focus on AML
So it is :( I'm known to have poor spelling and grammar tbh
Yes, volume is very low not many want to give up their seats at this level. My only disappointment is that I don't have any more money to plow into hemo!
Not it's not clutching at straws it's understanding what's happening in the hemo social circle.
Kbl merger*
I did read the whole thing but I don't get it tbh.
So it's a listing not a sale, what are only merger doing for 180? Are they facilitating the listing process?
Thanks for sharing that CJ, I don't fully understand that document, 180 life sciences is being sold?
Note that James Woody, Marc Feldmann and Ozan Pamir are part of 180 and Enosi.
That's how I found it because Vlad liked it on LinkedIn :D
There's no reason to think we are losing our board members. Board members hold multiple positions and it's their job to provide oversight, guidance and strategy, they're obviously not 9-5 day in day out workers. More fingers in more pies is a great thing to have in a board member.
Vlad is tweeting so much about covid